Home › Hemophilia B › Georgia
Hemophilia B clinical trials in Georgia
4 studies for Hemophilia B are looking for participants at sites in Georgia.
Cities in Georgia
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- Arthur M. Blank Hospital - Children's Healthcare of Atlanta, Atlanta
RecruitingPhase 3
138 Months – 206 Months · Men · Updated Sep 16, 2026 · NCT07080905SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
- Children's Healthcare of Atlanta, Atlanta
- Emory University Hospital, Atlanta
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Aug 21, 2026 · NCT04563520ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
- Emory/Children's Health Care of Atlanta, Atlanta
- Memorial Health University Medical Center, Savannah
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division, Atlanta
- Willett Children's Hospital at Memorial University Medical Center, Savannah
RecruitingPhase 4
Ages 12 to 100 · All sexes · Updated Jan 12, 2026 · NCT04647227From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.